Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-172143
Filing Date
2014-04-30
Accepted
2014-04-30 16:16:59
Documents
9
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d697509d10q.htm 10-Q 488662
2 EX-31.1 d697509dex311.htm EX-31.1 6027
3 EX-32.1 d697509dex321.htm EX-32.1 2590
  Complete submission text file 0001193125-14-172143.txt   3484723

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT ogxi-20140331.xml EX-101.INS 408525
5 XBRL TAXONOMY EXTENSION SCHEMA ogxi-20140331.xsd EX-101.SCH 34462
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ogxi-20140331_cal.xml EX-101.CAL 48190
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ogxi-20140331_def.xml EX-101.DEF 121391
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE ogxi-20140331_lab.xml EX-101.LAB 302085
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ogxi-20140331_pre.xml EX-101.PRE 217153
Mailing Address 1522 217TH PLACE S.E. BOTHELL WA 98021
Business Address 1522 217TH PLACE S.E. BOTHELL WA 98021 4254879500
ONCOGENEX PHARMACEUTICALS, INC. (Filer) CIK: 0000949858 (see all company filings)

EIN.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 033-80623 | Film No.: 14798959
SIC: 2835 In Vitro & In Vivo Diagnostic Substances